NDC 62756-0356-64
ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING
Available — 2-Day Shipping
NDC
62756-0356-64
Generic Name
ondansetron
Brand Name
ondansetron
Strength
8 mg/1
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Package Size
—
Labeler
Sun Pharmaceutical Industries, Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Ondansetron is indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . initial and repeat courses of moderately emetogenic cancer chemotherapy. radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. Ondansetron is also indicated for the prevention of postoperative nausea and/or…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All ondansetron Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other ondansetron NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 62756-0356-64 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).